Mattias Hällbrink
Research Specialist
E-mail: mattias.hallbrink@ki.se
Visiting address: Blickagången 6, 14157 Huddinge
Postal address: H5 Laboratoriemedicin, H5 BCM El Andaloussi Daniel Hagey, 141 52 Huddinge
Articles
- Article: BIOMEDICINES. 2021;9(8):1046Bazaz S; Lehto T; Tops R; Gissberg O; Gupta D; Bestas B; Bost J; Wiklander OPB; Sork H; Zaghloul EM; Mamand DR; Hallbrink M; Sillard R; Saher O; Ezzat K; Smith CIE; El Andaloussi S; Lehto T
- Article: PHARMACEUTICS. 2021;13(6):878Gustafsson O; Radler J; Roudi S; Lehto T; Hallbrink M; Lehto T; Gupta D; EL Andaloussi S; Nordin JZ
- Article: MICROPOROUS AND MESOPOROUS MATERIALS. 2020;300:110173Abdelhamid HN; Dowaidar M; Hallbrink M; Langel U
- Article: FASEB JOURNAL. 2019;33(10):11314-11325van der Bent ML; Paulino da Silva Filho O; Willemse M; Hällbrink M; Wansink DG; Brock R
- Article: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2019;141:180-190van den Brand D; Gorris MAJ; van Asbeck AH; Palmen E; Ebisch I; Dolstra H; Hällbrink M; Massuger LFAG; Brock R
- Article: JOURNAL OF BIOMATERIALS APPLICATIONS. 2018;33(3):392-401Dowaidar M; Nasser Abdelhamid H; Hällbrink M; Langel Ü; Zou X
- Article: PEPTIDES. 2018;104:62-69Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
- Article: BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2018;1860(2):491-504Vasconcelos L; Lehto T; Madani F; Radoi V; Hallbrink M; Vukojevic V; Langel U
- Article: SCIENTIFIC REPORTS. 2017;7(1):12635Dowaidar M; Gestin M; Cerrato CP; Jafferali MH; Margus H; Kivistik PA; Ezzat K; Hallberg E; Pooga M; Hallbrink M; Langel U
- Article: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2017;1861(9):2334-2341Dowaidar M; Abdelhamid HN; Hällbrink M; Zou X; Langel Ü
- Article: SCIENTIFIC REPORTS. 2017;7(1):9159Dowaidar M; Abdelhamid HN; Hällbrink M; Freimann K; Kurrikoff K; Zou X; Langel Ü
- Article: NUCLEIC ACIDS RESEARCH. 2017;45(9):5153-5169Zaghloul EM; Gissberg O; Moreno PMD; Siggens L; Hallbrink M; Jorgensen AS; Ekwall K; Zain R; Wengel J; Lundin KE; Smith CIE
- Article: BIOCONJUGATE CHEMISTRY. 2017;28(3):782-792Lehto T; Vasconcelos L; Margus H; Figueroa R; Pooga M; Hällbrink M; Langel Ü
- Article: INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. 2017;23(1):91-100Dowaidar M; Regberg J; Dobchev DA; Lehto T; Hallbrink M; Karelson M; Langel U
- Article: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2016;501(1-2):32-38Regberg J; Vasconcelos L; Madani F; Langel U; Hallbrink M
- Article: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2016;500(1-2):128-135Srimanee A; Regberg J; Hällbrink M; Vajragupta O; Langel Ü
- Article: MOLECULAR THERAPY NUCLEIC ACIDS. 2016;5(3):e290Sork H; Nordin JZ; Turunen JJ; Wiklander OPB; Bestas B; Zaghloul EM; Margus H; Padari K; Duru AD; Corso G; Bost J; Vader P; Pooga M; Smith CIE; Wood MJA; Schiffelers RM; Hallbrink M; Andaloussi SEL
- Article: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2015;11(4):879-883Nordin JZ; Lee Y; Vader P; Maeger I; Johansson HJ; Heusermann W; Wiklander OPB; Hallbrink M; Seow Y; Bultema JJ; Gilthorpe J; Davies T; Fairchild PJ; Gabrielsson S; Meisner-Kober NC; Lehtio J; Smith CIE; Wood MJA; Andaloussi SEL
- Article: NUCLEIC ACID THERAPEUTICS. 2015;25(2):65-77Jarver P; Zaghloul EM; Arzumanov AA; Saleh AF; McClorey G; Hammond SM; Hallbrink M; Langel U; Smith CIE; Wood MJA; Gait MJ; EL Andaloussi S
- Article: METHODS IN MOLECULAR BIOLOGY. 2015;1324:303-315Arukuusk P; Pärnaste L; Hällbrink M; Langel Ü
- Show more
All other publications
- Review: METHODS IN MOLECULAR BIOLOGY. 2015;1324:39-58Hällbrink M; Karelson M
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2000;21(3):99-103Lindgren M; Hällbrink M; Prochiantz A; Langel U
- Review: FRONTIERS IN BIOSCIENCE - LANDMARK. 1999;4:D782-D786Soomets U; Hällbrink M; Langel U
- Published conference paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1998;863:450-453Pooga M; Lindgren M; Hällbrink M; Bråkenhielm E; Langel U